These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18714321)

  • 1. How European regulators view foreign data in the approval process.
    Breckenridge A; Hudson I
    Clin Pharmacol Ther; 2008 Sep; 84(3):311-2. PubMed ID: 18714321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
    Reeve LM
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food packaging regulation in the United States and the European Union.
    Heckman JH
    Regul Toxicol Pharmacol; 2005 Jun; 42(1):96-122. PubMed ID: 15896448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teaching the elephant to dance: privatizing the FDA review process.
    Price EC
    Food Drug Law J; 1996; 51(4):651-76. PubMed ID: 11797734
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency.
    Bottomley A; Jones D; Claassens L
    Eur J Cancer; 2009 Feb; 45(3):347-53. PubMed ID: 19013787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of FDA's proposal to include foreign marketing experience in the over-the-counter drug review process.
    Pinco RG
    Food Drug Law J; 1998; 53(1):105-22. PubMed ID: 11795327
    [No Abstract]   [Full Text] [Related]  

  • 7. Current regulatory and legal considerations for follow-on biologics.
    Kingham RF; Lietzan E
    Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615
    [No Abstract]   [Full Text] [Related]  

  • 8. Assuring the quality, safety, and efficacy of DNA vaccines.
    Robertson JS; Griffiths E
    Methods Mol Med; 2006; 127():363-74. PubMed ID: 16988466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

  • 10. Lost in translation: differences in antimicrobial indication approval policies between the United States and Europe.
    Pappas G; Ierodiakonou V; Falagas ME
    Clin Ther; 2009 Jul; 31(7):1595-603. PubMed ID: 19695409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food and Drug Administration approval process for ophthalmic drugs in the US.
    Lloyd R; Harris J; Wadhwa S; Chambers W
    Curr Opin Ophthalmol; 2008 May; 19(3):190-4. PubMed ID: 18408492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficult decisions.
    Nat Med; 2011 Aug; 17(8):901. PubMed ID: 21818065
    [No Abstract]   [Full Text] [Related]  

  • 13. Global harmonization of regulatory requirements for premarket approval of autologous cell therapies.
    Ward SM
    Food Drug Law J; 2000; 55(2):225-43. PubMed ID: 12269366
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteriation of clinical data packages using foreign data in new drug applications in Japan.
    Tanaka M; Nagata T
    Clin Pharmacol Ther; 2008 Sep; 84(3):340-6. PubMed ID: 17786162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting, improving and accelerating the drug development and approval processes.
    Graul AI
    Drug News Perspect; 2008; 21(1):36-43. PubMed ID: 18301808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has the food and drug administration changed the drug approval process?
    Somberg JC
    Am J Ther; 2011 May; 18(3):179. PubMed ID: 21566467
    [No Abstract]   [Full Text] [Related]  

  • 17. When EMA and FDA decisions conflict: differences in patients or in regulation?
    Wolfe SM
    BMJ; 2013 Aug; 347():f5140. PubMed ID: 23970394
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of international cooperation.
    Holston SS
    Food Drug Law J; 1997; 52(2):197-201. PubMed ID: 10557560
    [No Abstract]   [Full Text] [Related]  

  • 19. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
    Purnhagen KP
    Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663
    [No Abstract]   [Full Text] [Related]  

  • 20. Equivalence and regulatory approaches of nonbiological complex drug products across the United States, the European Union, and Turkey.
    Oner ZG; Michel SLJ; Polli JE
    Ann N Y Acad Sci; 2017 Nov; 1407(1):26-38. PubMed ID: 29090833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.